ברינרט - Berinert

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

B06AC
Drugs used in hereditary angioedema

××¨××× ×¤×¢×× (ATC5)

C - 1 ESTERASE INHIBITOR HUMAN 500 IU/VIAL âB06AC01

×¦××¨×ª ××ª×

×ª××-××¨××× - I.V

×¦××¨×ª ××× ××

×××§× ××××¡ ×××× ×ª ×ª×××¡× ××××¨×§×\××× ×¤××××, POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Hereditary angioedema type I and II (HAE).Treatment and pre-procedure (prior to oral, dental, and upper respiratory tract procedures) prevention of acute episodes

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

10/01/2012

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×¡×××¤××××× ×××ª×§×¤×× ××¨××¤×× ×©× ×× ××××××× ×ª××¨×©×ª××ª ×××××× ×¢× ××¡×¨ ×-C1 esterase inhibitor ××××ª×§××× ×× ×××:

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 30.04.2016
××××¨× ××¢××× ××¨××¤× 04.08.2015 (××¡×× Microsoft Word)

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 30.04.2016 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 30.04.2016 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 30.04.2016

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××¨×× ×¨× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	CSL BEHRING GmbH, GERMANY
×©× ××¢× ××¨××©××	CSL BEHRING LTD., ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 10/2009. ×¨××©××× ××ª××¨××: 12/2015
×ª××¨×× ×¢×××× ×××¨××	14/05/19

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־23 באוגוסט 2025 ב־07:12

ברינרט - Berinert

ויקיתרופות